CEACAM5 and neoplasm: employed a neural network algorithm, encompassing indicators such as PLR, SII, tumor size, cN stage, Carcinoembryonic Antigen (CEA), and Cancer Antigen 199 (CA199) for stage II-III gastric cancer patients.